2023
DOI: 10.1002/cia2.12311
|View full text |Cite
|
Sign up to set email alerts
|

Dupilumab aggravates Sézary syndrome: The importance of accurate pathological diagnosis

Abstract: We report a case of Sézary syndrome aggravated by dupilumab. Although a diagnosis of atopic dermatitis was made previously, our retrospective diagnosis was cutaneous T‐cell lymphoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 19 publications
0
0
0
Order By: Relevance